Abstract
Ferumoxytol (Rienso) is a new intravenous iron formulation for the treatment of iron‐deficiency anaemia in chronic kidney disease. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Matthew Brookes discusses its place in the treatment of iron‐deficiency anaemia.
Cite
CITATION STYLE
APA
Chaplin, S., & Brookes, M. (2013). Ferumoxytol (Rienso): new intravenous iron preparation. Prescriber, 24(9), 25–27. https://doi.org/10.1002/psb.1052
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free